Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/50577 
Erscheinungsjahr: 
2009
Schriftenreihe/Nr.: 
School of Economics Discussion Papers No. 09,19
Verlag: 
University of Kent, School of Economics, Canterbury
Zusammenfassung: 
We consider a policy game between a high-income country hosting a drug innovator and a low-income country hosting a drug imitator. The low-income country chooses whether to enforce an International Patent Regime (strict IPR) or not (weak IPR) and the high-income country chooses whether to allow parallel imports (PI) of on-patent drugs or market based discrimination (MBD). We show that, for a moderately high imitation cost, both (Strict IPR, Parallel Imports) and (Weak IPR, MBD) emerge as the Subgame Perfect Nash Equilibrium (SPNE) policy choices. For relatively smaller imitation costs, (Weak IPR, MBD) is the unique SPNE policy choice. The welfare properties reveal that although innovation may be higher at the (Strict IPR, PI), the market coverage and national welfare of the low-income country, and the total welfare are all lower. This opens up the efficiency issue of implementing TRIPS and at the same time allowing international exhaustion of patent rights.
Schlagwörter: 
patent protection
TRIPS
innovation
imitation
parallel imports
pharmaceuticals
JEL: 
D4
L1
I1
Dokumentart: 
Working Paper

Datei(en):
Datei
Größe
404.83 kB





Publikationen in EconStor sind urheberrechtlich geschützt.